Eduardo R Cobo Selected Research

Amebic Dysentery (Amoebic Dysentery)

1/2018	Entamoeba histolytica Alters Ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency.
1/2017	MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
6/2012	A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target.
1/2012	Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eduardo R Cobo Research Topics

Disease

11	Infections 03/2021 - 12/2009
5	Muscle Cramp (Cramp) 07/2022 - 01/2012
5	Inflammation (Inflammations) 01/2021 - 06/2010
4	Colitis 01/2021 - 01/2017
4	Amebic Dysentery (Amoebic Dysentery) 01/2018 - 01/2012
3	Mastitis 01/2020 - 02/2019
2	Digital Dermatitis 06/2021 - 02/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2013
2	Communicable Diseases (Infectious Diseases) 06/2018 - 11/2017
2	Amebiasis (Amoebiasis) 06/2012 - 06/2010
1	Peritonitis 03/2021
1	Carcinogenesis 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	protothecosis 01/2020
1	Paratuberculosis (Johne's Disease) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2019
1	Bovine Mastitis 06/2018
1	Enterocolitis 12/2016
1	Noncommunicable Diseases 03/2013
1	Rheumatoid Arthritis 06/2012
1	Amebic Liver Abscess 06/2012

Drug/Important Bio-Agent (IBA)

11	CathelicidinsIBA 07/2022 - 01/2012
6	Peptides (Polypeptides)IBA 07/2022 - 06/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 10/2011
3	AntigensIBA 03/2016 - 12/2009
3	Cysteine Proteases (Cysteine Protease)IBA 03/2012 - 06/2010
2	MucinsIBA 07/2022 - 01/2017
2	Dextrans (Dextran)FDA Link 01/2021 - 01/2017
2	DefensinsIBA 02/2020 - 03/2013
2	CytokinesIBA 01/2020 - 01/2017
2	Antimicrobial PeptidesIBA 01/2017 - 01/2012
2	divinyl sulfoneIBA 03/2012 - 06/2010
2	Immunoglobulin G (IgG)IBA 04/2011 - 12/2009
2	AntibodiesIBA 04/2011 - 12/2009
1	Culture MediaIBA 06/2021
1	nitrobenzeneIBA 01/2021
1	AzoxymethaneIBA 01/2021
1	fluorescein isothiocyanate dextranIBA 01/2021
1	AcidsIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	SodiumIBA 01/2021
1	OvalbuminIBA 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 02/2020
1	Oxytetracycline (Terramycin)FDA Link 02/2020
1	Antimicrobial Cationic PeptidesIBA 01/2020
1	nasIBA 02/2019
1	Muramidase (Lysozyme)IBA 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	Butyrates (Butyrate)IBA 01/2017
1	Pharmaceutical PreparationsIBA 06/2012
1	Auranofin (Ridaura)FDA Link 06/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012
1	Metronidazole (Metric)FDA LinkGeneric 10/2011
1	Estrogens (Estrogen)FDA Link 10/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2011
1	EnzymesIBA 06/2010

Therapy/Procedure

5	Therapeutics 01/2021 - 06/2012
2	Intraperitoneal Injections 07/2022 - 01/2021